Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias

Am J Hematol. 2015 Aug;90(8):E149-51. doi: 10.1002/ajh.24047.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anemia, Hemolytic, Autoimmune / blood
  • Anemia, Hemolytic, Autoimmune / pathology
  • Anemia, Hemolytic, Autoimmune / surgery
  • Anemia, Hemolytic, Autoimmune / therapy*
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Erythrocytes / drug effects
  • Erythrocytes / pathology
  • Hemolysis
  • Humans
  • Immunologic Factors / therapeutic use*
  • Lenalidomide
  • Plasma Exchange
  • Rituximab
  • Severity of Illness Index
  • Splenectomy
  • Steroids / therapeutic use*
  • Thalidomide / analogs & derivatives*
  • Thalidomide / therapeutic use
  • Time-to-Treatment
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Steroids
  • Rituximab
  • Thalidomide
  • Lenalidomide